| Literature DB >> 33364394 |
Yoshiaki Inuzuka1, Kunio Mizutari1, Daisuke Kamide2, Michiya Sato2, Akihiro Shiotani1.
Abstract
OBJECTIVE: Tonsillectomy is an essential surgery and is conducted on both children and adults. However, the risk factors of post-tonsillectomy hemorrhage for adult patients remain unclear. In this study, we analyzed post-tonsillectomy hemorrhage in adult patients.Entities:
Keywords: adult; adult tonsillectomy; postoperative hemorrhage; smoking
Year: 2020 PMID: 33364394 PMCID: PMC7752073 DOI: 10.1002/lio2.488
Source DB: PubMed Journal: Laryngoscope Investig Otolaryngol ISSN: 2378-8038
PTH classification based on Windfuhr's categorization of what procedure was done for hemostasis
| Grade 1 | Bleeding with a spontaneous cessation |
| Grade 2 | Treatment under local anesthesia |
| Grade 3 | Treatment under general anesthesia |
| Grade 4 | Ligation of external carotid artery |
| Grade 5 | Death |
Number of patients undergone tonsillectomy and the overall PTH, primary hemorrhage, and secondary hemorrhage
| Indication | No. of patients | Overall PTH n (%) | Primary hemorrhage n (%) | Secondary hemorrhage n (%) |
|---|---|---|---|---|
| Chronic/recurrent tonsillitis | 240 | 55 (22.9) | 6 (2.5) | 49 (20.4) |
|
| ||||
| IgA nephropathy | 46 | 7 (15.2) | 1 (2.2) | 6 (13.0) |
| Palmoplantar pustulosis | 2 | 0 (0) | 0 (0) | 0 (0) |
| SAS | 34 | 9 (26.5) | 1 (2.9) | 8 (23.5) |
| Tonsil hypertrophy | 3 | 0 (0) | 0 (0) | 0 (0) |
| Total | 325 | 71 (21.8) | 8 (2.5) | 63 (19.4) |
Abbreviation: SAS, sleep apnea syndrome.
FIGURE 1Periods and categories of PTH. Among the 71 patients, eight had primary hemorrhage, and 63 had secondary hemorrhage. There were two peaks of frequency on postoperative days 0 and 6
The clinical data for patients of the non‐PTH, primary hemorrhage, and secondary hemorrhage groups
| Non‐PTH (n = 254) | PTH (n = 71) |
| Primary hemorrhage (n = 8) |
| Secondary hemorrhage (n = 63) |
| |
|---|---|---|---|---|---|---|---|
|
| |||||||
| (Average, year old) | 31.5 | 32.6 | .48 | 43.9 | .004 | 31.1 | .85 |
|
| |||||||
| Male | 185 | 65 | <.001 | 8 | .12 | 57 | .003 |
| Female | 69 | 6 | 0 | 6 | |||
|
| |||||||
| ≧25 | 85 | 23 | 1.00 | 4 | .45 | 19 | .66 |
| <25 | 169 | 48 | 4 | 44 | |||
|
| |||||||
| Current | 41 | 29 | <.001 | 4 | .03 | 25 | <.001 |
| Ex | 59 | 15 | 2 | 13 | |||
| Never | 154 | 27 | 2 | 25 | |||
| Operative time (average, min) | 78.2 | 77.1 | .97 | 63.9 | .16 | 78.8 | .62 |
|
| |||||||
| Continued orally | 186 | 49 | 0.55 | 6 | 1.00 | 43 | .44 |
| Only injection | 68 | 22 | 2 | 20 | |||
|
| |||||||
| NSAIDs | 226 | 70 | 0.06 | 8 | 1.00 | 62 | .14 |
| Acetaminophen | 20 | 1 | 0 | 1 | |||
Note: P‐values demonstrate the results of univariate analysis compared to the non‐PTH group.
Abbreviation: NSAIDs, non‐steroidal anti‐inflammatory drugs.
P < .05.
P < .01.
P < .001.
Multiple logistic regression analysis for risk factors of overall PTH, primary hemorrhage, and secondary hemorrhage
| PTH (n = 71) | Primary hemorrhage (n = 8) | Secondary hemorrhage (n = 63) | ||||
|---|---|---|---|---|---|---|
| Factor | OR (95% CI) |
| OR (95% CI) |
| OR (95% CI) |
|
| Age | 1.02 (0.99‐1.05) | 0.24 | 1.14 (1.05–1.25) | 0.003 | 1.00 (0.97‐1.04) | 0.79 |
| Male gender | 3.92 (1.55–9.94) | 0.004 | — | — | 3.54 (1.39–8.98) | 0.008 |
| Obesity | 0.64 (0.34‐1.22) | 0.17 | 0.55 (0.09‐3.26) | 0.51 | 0.62 (0.31‐1.22) | 0.16 |
| Smoking: current vs never | 3.49 (1.81–6.72) | <0.001 | 7.24 (1.03–50.91) | 0.047 | 3.32 (1.68–6.58) | <0.001 |
| Smoking: current vs ex | 3.47 (1.59–7.58) | 0.002 | 9.80 (1.12–85.83) | 0.04 | 3.22 (1.42‐7.33) | 0.005 |
| Smoking: ex vs never | 1.01 (0.48‐2.12) | 0.99 | 0.74 (0.08‐6.73) | 0.79 | 1.03 (0.47‐2.25) | 0.94 |
| Operative time | 1.00 (0.99‐1.01) | 0.72 | 0.97 (0.94‐1.01) | 0.13 | 1.00 (0.99‐1.01) | 0.89 |
| Antibiotics | 0.84 (0.45‐1.55) | 0.57 | 0.96 (0.16‐5.73) | 0.97 | 0.82 (0.43‐1.56) | 0.55 |
| Analgesia: NSAIDs | 7.93 (1.004–62.64) | 0.0496 | — | — | 6.94 (0.87‐55.39) | 0.07 |
Abbreviation: NSAIDs, non‐steroidal anti‐inflammatory drugs.
P < .05.
P < .01.
P < .001.